Related Experiment Videos
The distinct health risk analyses required for genotoxic carcinogens and promoting agents
Abstract:
Health risk analysis needs to apply newer developments in the understanding of the underlying mechanisms of the carcinogenic process which has allowed for the classification of chemical carcinogens into those that damage genetic material directly (genotoxic carcinogens) and those that operate by indirect or epigenetic mechanisms. We propose a systematic decision point approach for detecting and evaluating substances for carcinogenic risk. This approach recognizes that genotoxic and epigenetic agents operate by different mechanisms and distinguishes between these two categories of carcinogens primarily on the basis of results in a battery of short-term tests that includes systems which reliably detect genotoxic carcinogens and others which may respond to epigenetic agents. Genotoxic carcinogens at very low dosages may have practical, effective threshold no-effect levels, but, nevertheless, because of their mechanism of action they are regarded as a qualitative hazard. The action of epigenetic agents of the promoter class is highly dose-dependent and reversible, and thus, a distinctively different health risk analysis is required for these agents to take account of their quantitatively lesser hazard.
Insights
Health risk analysis requires distinguishing between genotoxic carcinogens and epigenetic agents. A new systematic approach uses short-term tests to evaluate carcinogenic risk based on distinct mechanisms and dose-dependency.
Area of Science:
- Toxicology
- Carcinogenesis
- Risk Assessment
Background:
- Understanding of carcinogenic mechanisms has evolved, classifying agents as genotoxic or epigenetic.
- Traditional risk assessments may not adequately address the distinct properties of these carcinogen classes.
Purpose of the Study:
- To propose a systematic decision point approach for evaluating carcinogenic risk.
- To differentiate between genotoxic and epigenetic carcinogens based on their mechanisms of action.
Main Methods:
- Utilizing a battery of short-term tests to detect genotoxic carcinogens.
- Employing additional tests to identify potential epigenetic agents.
Main Results:
- Genotoxic carcinogens are classified as qualitative hazards due to direct genetic material damage.
- Epigenetic agents, particularly promoters, exhibit dose-dependent and reversible effects.
Conclusions:
- A distinct health risk analysis is necessary for genotoxic and epigenetic carcinogens.
- The proposed approach accounts for differing mechanisms and dose-response relationships for accurate risk assessment.